Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05763966

Uppsala Psychosis Cohort

Uppsala Psychosis Cohort: a Multimodal Study in Early Stage Psychosis Patients, High Risk Individuals and Healthy Controls

Status
Recruiting
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Uppsala University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

A multimodal longitudinal study in early stage psychosis patients and individuals at high risk for psychosis. Healthy controls are included for baseline comparisons. The aim is to investigate disease mechanisms of psychotic disorders, specifically focusing on the synaptic pruning hypothesis.

Detailed description

This is a single-site observational study examining synaptic density using positron emission tomography (PET) and the radioligand \[18F\]SynVest-1 binding to the synaptic vesicle glycoprotein 2A. In addition to PET, the study includes clinical assessment, cognitive testing, multimodal magnetic resonance imaging (MRI) measures, neurophysiological measures, lumbar punction for cerebrospinal fluid (CSF) analyses, blood sampling, heart rate variability measures. Early stage psychosis patients and clinical high-risk individuals are subject to repeat assessment after 1 year (including PET), and at 3 and 5 years.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionObservational study where participants are followed over time

Timeline

Start date
2023-04-01
Primary completion
2026-12-31
Completion
2031-12-31
First posted
2023-03-10
Last updated
2025-02-20

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT05763966. Inclusion in this directory is not an endorsement.